Skip to content

Next-Generation Sequencing (NGS) Market Development Insights and Predictions (2025-2032) | Increased Research and Development Financing Fuels Growth, Reductions in Sequencing Costs Amplify Accessibility and Acceptance - ResearchAndMarkets.com

Report on the "Growth Analysis and Forecast for the Clinical Next Generation Sequencing (NGS) Market spanning 2025 to 2032" has been released, according to Business Wire.

Research and Markets.com Releases Report on Clinical Next Generation Sequencing (NGS) Market,...
Research and Markets.com Releases Report on Clinical Next Generation Sequencing (NGS) Market, Showing Increasing Growth Due to Substantial Research and Development Investments, Falling Sequencing Costs Expanding Accessibility and Adoption

Next-Generation Sequencing (NGS) Market Development Insights and Predictions (2025-2032) | Increased Research and Development Financing Fuels Growth, Reductions in Sequencing Costs Amplify Accessibility and Acceptance - ResearchAndMarkets.com

In the realm of international market research, ResearchAndMarkets.com stands as a leading source for reports and data. While a specific forecast for the clinical NGS market isn't exclusively available, broader trends in the next-generation sequencing (NGS) market offer valuable insights.

According to various sources, the global NGS market is predicted to grow substantially. Persistency Market Research projects a growth from approximately $8.42 billion in 2021 to $33.3 billion by 2032, with a Compound Annual Growth Rate (CAGR) of 21.7%. Another source suggests a growth from $10.44 billion to $27.55 billion, with a CAGR of 14.9%.

The clinical segment within the NGS market has been noted to hold a dominant position, driven by the increasing use of NGS in clinical diagnostics. This suggests that the clinical segment is significant within the overall NGS market.

The global clinical NGS market was valued at USD 6.2 billion in 2024. It is segmented by product type into Instruments, Workflow Solutions, Informatics, and Services, and by workflow into Library Preparation, Sequencing, Data Analysis and Interpretation.

The market growth is fuelled by the increasing demand for personalized medicine and the urgency to advance diagnostic capabilities to combat infectious diseases. Moreover, significant investments in research and development further stimulate market expansion.

Key players in the global clinical NGS market include Roche, Qiagen, Illumina Inc., Thermo Fisher Scientific Inc., and others. The market is segmented geographically into North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World (RoW).

The report presented by ResearchAndMarkets.com offers an in-depth assessment of the global clinical NGS market dynamics, opportunities, future roadmap, competitive landscape, and major trends. It also includes profiles of major market players and provides a detailed analysis of the current industry situation and market requirements.

For those interested in staying updated on the latest trends and developments in the global clinical NGS market, ResearchAndMarkets.com offers contact information for email and phone numbers across various time zones. For more specific and detailed market research or sector forecasts, further investigation may be necessary.

Read also:

Latest